Answers are grounded in this paper and cite their sources.
Metaplastic breast carcinoma (BC-Mp) is an uncommon subtype that poses unique challenges. The limited information on patient prognosis and therapeutic strategies motivated our research initiative. We aimed to assess disease-free survival (DFS), overall survival (OS), and influential factors in patients with nonmetastatic BC-Mp.
No takes yet. Share an insight, caveat, or question.
Püsküllüoğlu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: